Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 36 Neoplasm Metastasis 10 Neoplasms 7 Brain Neoplasms 4 Triple Negative Breast Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Advanced Malignant Solid Tumors 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Thrombocytosis 1 Solid Tumor 1 Salivary Gland Neoplasms 1 Recurrence 1 Rare Tumour 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Meningioma 1 Malignant Female Reproductive System Neoplasm 1

Interventions

Gemcitabine 92 Cisplatin 70 Oxaliplatin 37 Capecitabine 37 durvalumab 29 Fluorouracil 26 pembrolizumab 24 Leucovorin 22 S 1 (combination) 18 Nivolumab 13 Irinotecan 13 Bevacizumab 13 lenvatinib 12 tremelimumab 10 apatinib 8 Trastuzumab 7 Injections 7 Albumin-Bound Paclitaxel 7 130-nm albumin-bound paclitaxel 7 Paclitaxel 6 Immune Checkpoint Inhibitors 6 Docetaxel 6 titanium silicide 5 surufatinib 5 envafolimab 5 camrelizumab 5 atezolizumab 5 Folfox protocol 5 Drug Therapy 5 Carboplatin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Biliary Tract Neoplasms × neratinib × Clear all

NCT05615818 2026-05-19

SAFIR-ABC10

UNICANCER

Phase 3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡